Cargando…

Tumour growth and anti-mitotic action. The role of spontaneous cell losses.

Detalles Bibliográficos
Autor principal:	Bagshawe, K. D.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1968
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2008372/ https://www.ncbi.nlm.nih.gov/pubmed/5705140

Ejemplares similares

The effect of neuraminidase on the immunogenicity of the Landschütz ascites tumour: site and mode of action.
por: Currie, G. A., et al.
Publicado: (1968)

Anti-mitotic Activity of Bleomycin: Time of Action in the Mammalian Cell Cycle
por: Wheatley, D. N., et al.
Publicado: (1974)

Cyclosporin A prevents the anti-murine antibody response to a monoclonal anti-tumour antibody in rabbits.
por: Ledermann, J. A., et al.
Publicado: (1988)

The role of sialic acid in antigenic expression: further studies of the Landschütz ascites tumour.
por: Currie, G. A., et al.
Publicado: (1968)

Proceedings: The value of hormone measurements in tumour management.
por: Bagshawe, K. D.
Publicado: (1974)

Frequency of serum tumour marker monitoring in patients with non-seminomatous germ cell tumours.
por: Seckl, M. J., et al.
Publicado: (1990)

Tumour specific immunogenicity of methylcholanthrene-induced sarcoma cells after incubation in neuraminidase.
por: Currie, G. A., et al.
Publicado: (1969)

Serum folate and FIGLU excretion in patients with trophoblastic tumours.
por: Hughes, M., et al.
Publicado: (1968)

Trial of an aromatic retinoid in patients with solid tumours.
por: Rustin, G. J., et al.
Publicado: (1982)

Cellular Reaction in Trophoblastic Tumours
por: Elston, C. W., et al.
Publicado: (1973)

ORAL CONTRACEPTIVES AND POST-MOLAR TROPHOBLASTIC TUMOURS
por: Bagshawe, K.D., et al.
Publicado: (1980)

Third Gordon Hamilton-Fairley Memorial Lecture. Tumour markers--where do we go from here?
por: Bagshawe, K. D.
Publicado: (1983)

Pharmacologically-induced mitotic synchrony in airway epithelial cells as a mechanism of action of anti-inflammatory drugs
por: Freishtat, R J, et al.
Publicado: (2015)

Brain metastases in malignant teratoma: a review of four years' experience and an assessment of the role of tumour markers.
por: Kaye, S. B., et al.
Publicado: (1979)

The growth and cell population kinetics of spontaneous tumours in domestic animals.
por: Owen, L. N., et al.
Publicado: (1969)

Antibody directed enzymes revive anti-cancer prodrugs concept.
por: Bagshawe, K. D.
Publicado: (1987)

The effect of serum CEA on the distribution and clearance of anti-CEA antibody in a pancreatic tumour xenograft model.
por: Pedley, R. B., et al.
Publicado: (1989)

Mammary Tumours in Hybrid Mice: Growth and Progression of Spontaneous Tumours
por: Foulds, L.
Publicado: (1949)

Recombinogenic Conditions Influence Partner Choice in Spontaneous Mitotic Recombination
por: Cauwood, James D., et al.
Publicado: (2013)

Tumour-marker levels and prognosis in malignant teratoma of the testis.
por: Germa-Lluch, J. R., et al.
Publicado: (1980)

Collaborative study of bronchial tumour-associated antigens.
por: Gennings, J. N., et al.
Publicado: (1981)

Assessment of inherent fluctuations of mitotic and labelling indices of human tumours.
por: Aherne, W. A., et al.
Publicado: (1977)

The potential of carboxypeptidase G2: antibody conjugates as anti-tumour agents. II. In vivo localising and clearance properties in a choriocarcinoma model.
por: Melton, R. G., et al.
Publicado: (1990)

Trastuzumab-DM1 causes tumour growth inhibition by mitotic catastrophe in trastuzumab-resistant breast cancer cells in vivo
por: Barok, Mark, et al.
Publicado: (2011)

The concentration of HCG in the plasma and spinal fluid of patients with trophoblastic tumours in the central nervous system.
por: Rushworth, A. G., et al.
Publicado: (1968)

Bone disease in testicular and extragonadal germ cell tumours.
por: Hitchins, R. N., et al.
Publicado: (1988)

The effect of intensity of administered treatment on the outcome of germ cell tumours treated with POMB/ACE chemotherapy.
por: Crawford, S. M., et al.
Publicado: (1989)

International symposium on gestational trophoblastic tumours: 23, 24 May 1979, Charing Cross Hospital, London
por: Newlands, E. S., et al.
Publicado: (1980)

Modulation of vinblastine cytotoxicity by dilantin (phenytoin) or the protein phosphatase inhibitor okadaic acid involves the potentiation of anti-mitotic effects and induction of apoptosis in human tumour cells.
por: Kawamura, K. I., et al.
Publicado: (1996)

Epidermal Mitotic Activity and the Induction of Skin Tumours in Mice
por: Bielschowsky, F., et al.
Publicado: (1949)

Problems of interpretation of serum concentrations of alpha-foetoprotein (AFP) in patients receiving cytotoxic chemotherapy for malignant germ cell tumours.
por: Coppack, S., et al.
Publicado: (1983)

Factors Determining the Action of Colchicine on Tumour Growth
por: Ludford, R. J.
Publicado: (1948)

Effects of nandrolone decanoate on the toxicity and anti-tumour action of CCNU and FU in murine tumours.
por: Bibby, M. C., et al.
Publicado: (1981)

Anti-mitotic therapies in cancer
por: Tischer, Julia, et al.
Publicado: (2019)

A Fine-Structure Map of Spontaneous Mitotic Crossovers in the Yeast Saccharomyces cerevisiae
por: Lee, Phoebe S., et al.
Publicado: (2009)

Spontaneous sister chromatid exchanges in mitotic chromosomes of cattle (Bos taurus L)
por: Di Berardino, D, et al.
Publicado: (1995)

VTT-006, an anti-mitotic compound, binds to the Ndc80 complex and suppresses cancer cell growth in vitro
por: Laine, Leena J., et al.
Publicado: (2021)

Epidermal Mitotic Activity and Carbohydrate Metabolism in the Tumour-bearing Mouse
por: Laws, J. O.
Publicado: (1952)

Limited Power of Growth of Spontaneous Benign Mammary Tumours in RIIIb Mice
por: Pullinger, B. D.
Publicado: (1954)

Tumour growth inhibition in mice by glycosylated recombinant human lymphotoxin: analysis of tumour-regional mononuclear cells involved with its action.
por: Funahashi, I., et al.
Publicado: (1993)

Cannot write session to /tmp/vufind_sessions/sess_j9n8biiluf6bje4j6gcdfqr96r